Clinical and electrophysiological evaluation of nerve function impairment following cessation of multidrug therapy in leprosy.
Seventeen multibacillary (MB) and 15 paucibacillary (PB) cases of leprosy who had had regular and adequate multidrug therapy (MDT) were examined clinically and electrophysiologically at periodic intervals for 1 year following cessation of MDT. All the major nerves were assessed for nerve function impairment (NFI). Overall, two MB (13.3%) and three PB (20%) cases showed signs of deterioration clinically and/or electrophysiologically. The nerve conduction (NC) follow-up studies revealed no significant improvement in the sensory conduction in both the MB and PB groups of nerves, whilst motor conduction showed a significant improvement at the first 6-monthly follow-up among the MB group of nerves. At the study onset, sensory impairment (MB = 62%, PB = 25%) predominated over motor in terms of both severity and frequency. The lower extremity was more frequently and severely affected than the upper in both groups of patients. As an individual test, NC measurement proved to be more sensitive in detecting NFI, but the combination of physical palpatation for nerve thickening and graded nylon test (GNT) was closely comparable to measurement of nerve conduction.
Foundation for Medical Research, R.G. Thadani Marg, Worli, Bombay, India.
G
G
Samant
V P
VP
Shetty
M W
MW
Uplekar
N H
NH
Antia
D001707:Biopsy, Needle; D004359:Drug Therapy, Combination; D004576:Electromyography; D004594:Electrophysiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use*; D007918:Leprosy / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D008137:Longitudinal Studies; D008297:Male; D009431:Neural Conduction; D010525:Peripheral Nerves / Q000473:pathology / Q000503:physiopathology; D010523:Peripheral Nervous System Diseases / Q000175:diagnosis* / Q000209:etiology* / Q000503:physiopathology; D011379:Prognosis; D012678:Sensation Disorders / Q000175:diagnosis* / Q000209:etiology* / Q000503:physiopathology; D012867:Skin / Q000473:pathology
D007917:Leprostatic Agents